Postoperative outcomes of dexmedetomidine, propofol or Sevoflurane anesthesia in children with cyanotic complex congenital heart defect undergoing cardiac surgery

Postoperative outcomes of dexmedetomidine, propofol or Sevoflurane anesthesia in Infancy children with cyanotic complex congenital heart defect undergoing cardiac surgery with BIS monitoring

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002788

Enrollment

Unknown

Registered

2012-12-12

Start date

2012-03-26

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cyanotic congenital heart disease

Interventions

group D:dexmedetomidine

group P:propofol

group S:Sevoflurane

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: children, 0-1 years, with cyanotic congenital heart disease undergoing elective surgery

Exclusion criteria

Exclusion criteria: Preoperative SaO2> 85%, the second surgery, emergency surgery, severe left ventricular dysfunction in children with single ventricle, severe liver and kidney, blood, and endocrine system abnormalities and airway inflammation in children

Design outcomes

Primary

Measure	Time frame
Hospital stay;Mortality rate;	—

Countries

China

Contacts

Public ContactQingZhao

zhaoqingmz2010@163.com+86 0551-2922344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026